Megasoft Restricted has determined to promote its complete 36.52 per cent holding in Extrovis AG, Switzerland, an affiliate firm, for $15 million (about ₹128 crore). The corporate stated the board has given its nod to the choice to promote the stake to Refex Life Sciences Personal Restricted.
The corporate stated it’ll search approval from its shareholders by means of a postal poll in the end.
Printed on July 1, 2025